Outcomes of Coronary Artery Bypass Grafting for Asymptomatic Patients Referred for Renal Transplant
- PMID: 40038064
- DOI: 10.1111/ctr.70128
Outcomes of Coronary Artery Bypass Grafting for Asymptomatic Patients Referred for Renal Transplant
Abstract
Background: The optimal management of incidental coronary artery disease (CAD) for renal transplant candidates is not well-defined. This study examined transplant and survival outcomes in patients undergoing coronary artery bypass grafting (CABG) for asymptomatic CAD.
Methods: A retrospective review of patients undergoing CABG solely to facilitate renal transplant was conducted at four tertiary centers. Exclusion criteria were symptoms or acute coronary syndrome (ACS). The primary outcomes were successful renal transplant and survival analyzed using Kaplan-Meier curves with log-rank testing, compared to US Renal Data System (USRDS)-predicted life expectancy matched for age and gender.
Results: 86 patients (59.0 [IQR 51.0,65.0] years, 88% male) were identified. At follow-up of 4.41 (2.74,6.04) years, 19.8% (n = 17) had successful renal transplant; 29.1% (n = 25) were never listed, 44.2% (n = 38) listed but removed (29 permanently, 9 temporarily), 7.0% (n = 6) awaiting transplant. Pre- and intraoperative characteristics were similar between those transplanted and not. For the entire cohort, CABG was associated with worse 1-year survival, similar 5-year survival, and better 8-year survival compared to USRDS-predicted life expectancy (log-rank p = 0.027). Considering those not transplanted, 8-year survival was similar to USRDS (log-rank p = 0.94).
Conclusions: In patients with Stage V CKD and asymptomatic CAD, renal transplant rates are low. Whether surgical revascularization offers survival benefit due to successful renal transplant or due to revascularization remains an area of future study. Longer follow-up, study of patient/procedural factors, and multidisciplinary efforts may improve patient selection and transplantation rates.
Keywords: coronary artery disease; kidney disease; recipient selection.
© 2025 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
References
-
- Q. Cai, V. K. Mukku, and M. Ahmad, “Coronary Artery Disease in Patients With Chronic Kidney Disease: A Clinical Update,” Current Cardiology Reviews 9 (2013): 331–339.
-
- M. R. Patel, J. H. Calhoon, G. J. Dehmer, et al., “ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 Appropriate Use Criteria for Coronary Revascularization in Patients With Stable Ischemic Heart Disease: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society of Thoracic Surgeons,” Journal of the American College of Cardiology 69, no. 17 (2017): 2212–2241.
-
- C. R. Matthews, J. B. Millward, Z. Faiza, et al., “Outcomes of Surgical Coronary Revascularization Performed Before Solid Abdominal Organ Transplants,” Annals of Thoracic Surgery 111, no. 2 (2021): 568–575, https://doi.org/10.1016/j.athoracsur.2020.05.077.
-
- United States Renal Data System. 2021 USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States (National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2021), https://usrds‐adr.niddk.nih.gov/2021/end‐stage‐renal‐disease/6‐mortality.
-
- G. Grolemund and H. Wickham, “Dates and Times Made Easy With Lubridate,” Journal of Statistical Software 40 (2011): 1–25.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous